Judicial Insight

Money & Corp · Court of Appeals for the Federal Circuit

Sep 30, 2026 · 24-1094 · Rehearing

A competitor challenges a representative about the validity of a medicine bottle patent in a lab.AI illustration

Teva fights back: should broad drug claims get another look?

Teva questions Eli Lilly's patent validity on headache treatment.

TL;DR

  1. 1Teva claims its drug patents are being unfairly restricted.
  2. 2Lilly argues that the claims are too broad and could block innovation.
  3. 3Industry voices warn that confusing patent rules could hurt medical progress.

Lower-court ruling unlocks after you vote

Does Teva get another hearing on their broad drug claims?

Be the first juror
Judge more cases